A global population of patients with prediabetes that is three times the size of those who already have Type 2 diabetes has led to intense competition between drug makers to launch drugs to treat the disease, according to a new report.
iHealth Lab Inc., today announced the release of two new fitness products to its existing lineup of wireless blood-pressure monitors and scales: the Wireless Pulse Oximeter and the Wireless Activity and Sleep Tracker. The company also announced new partnerships with two health and fitness communities, MyFitnessPal and RunKeeper.
Culturally competent coaching may be effective in reducing the risk of coronary artery disease among South Asian patients, according to a new study presented as a poster at an American Heart Association conference taking place in New Orleans.
iHealth Labs on Tuesday announced that its latest suite of products will be available for purchase at major retailers and online later this month. The iHealth wireless blood pressure wrist monitor, wireless blood pressure monitor and wireless body analysis scale are already available at Best Buy and iHealthlabs.com, the company added.
Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.
The increase in the number of people with rheumatoid arthritis, and the challenges posed to drug makers by generics, is encouraging the development of new drugs for the disease, according to a new report by Frost & Sullivan.